PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
5.38 - 5.60
4.95 - 8.28
2.3K / 2.4K (Avg.)
-279.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
2.54%
Positive revenue growth while HUH1V.HE is negative. John Neff might see a notable competitive edge here.
-5.90%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-8.41%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-8.41%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-10.47%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-8.60%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-8.60%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-2.06%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-2.06%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
42.67%
OCF growth at 75-90% of HUH1V.HE's 51.60%. Bill Ackman would demand better working capital management or cost discipline.
99.25%
FCF growth above 1.5x HUH1V.HE's 59.15%. David Dodd would verify if the firm’s strategic investments yield superior returns.
-29.49%
Negative 10Y revenue/share CAGR while HUH1V.HE stands at 84.56%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-4.39%
Negative 5Y CAGR while HUH1V.HE stands at 38.67%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
16.34%
3Y revenue/share CAGR at 75-90% of HUH1V.HE's 18.26%. Bill Ackman would expect new product strategies to close the gap.
-41.77%
Negative 10Y OCF/share CAGR while HUH1V.HE stands at 73.75%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-14.26%
Negative 5Y OCF/share CAGR while HUH1V.HE is at 195.39%. Joel Greenblatt would question the firm’s operational model or cost structure.
-31.60%
Negative 3Y OCF/share CAGR while HUH1V.HE stands at 70.84%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
138.09%
Net income/share CAGR above 1.5x HUH1V.HE's 62.23% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
56.90%
5Y net income/share CAGR 1.25-1.5x HUH1V.HE's 42.14%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
82.83%
Positive short-term CAGR while HUH1V.HE is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
52.58%
5Y equity/share CAGR is in line with HUH1V.HE's 53.79%. Walter Schloss would see parallel mid-term profitability and retention policies.
35.39%
3Y equity/share CAGR above 1.5x HUH1V.HE's 23.50%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-3.70%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-3.27%
Inventory is declining while HUH1V.HE stands at 0.89%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-0.08%
Negative asset growth while HUH1V.HE invests at 1.75%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
3.61%
50-75% of HUH1V.HE's 6.07%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
-1.14%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-12.62%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.